Skip to main content

Table 1 General characteristics of patients across insulin resistance presence

From: Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study

 

NIRG (n = 176)

IRG (n = 183)

 

n

%

n

%

p

Sex

 Males

156

88,60%

105

57,40%

0.005

Physical activity

 Sedentary

105

59,70%

117

64,60%

0.595

 Active

71

40,30%

66

36,50%

 

Clinical characteristics

 Previous myocardial revascularization

142

81%

142

78%

0.472

 Hypertension

166

94%

179

98%

0.09

 Type 2 diabetes mellitus

81

46%

98

54%

0.154

 Dyslipidemia

155

88%

161

88%

0.979

 CVD family history

131

74%

127

69%

0.299

Smoking status

 Current smoker

11

6%

11

6%

0.864

 Former smoker

97

55%

106

58%

 

 Nonsmoker

68

39%

66

36%

 

Drugs in use

 Acetylsalicylic acid

165

94%

171

93%

0.905

 Clopidogrel

11

6%

20

11%

0.114

 Beta-blocker

152

86%

155

85%

0.654

 Thiazide diuretics

38

22%

56

31%

0.06

 ACE inhibitors

86

49%

88

48%

0.883

 Angiotensin receptor blockers

47

27%

64

35%

0.09

 Calcium channel blockers

38

22%

63

34%

0.006

 Statin

166

94%

164

90%

0.102

 Metformin

71

40%

82

45%

0.392

 Insulin

23

13%

38

21%

0.05

  1. IRG group of patients with insulin resistance, NIRG group of patients non-insulin resistant, CVD cardiovascular disease, ACE inhibitors angiotensin-converting-enzyme inhibitor